journal article·2023-02-16Open access

Chitosan-coated liposomes of Carrisa spinarum extract: synthesis, analysis and anti-pneumococcal potency

Clarence Rubaka, Jeremiah Waweru Gathirwa, Hamisi M Malebo, Hulda Swai, Nicole Remaliah Samantha Sibuyi, Askwar Hilonga, Admire Dube

Abstract

In the present study, a chitosan (CS)-coated liposome (LipCsP-Chitosan) nanocarrier was fabricated for the delivery of Carissa spinarum (CsP) polyphenols to improve bioavailability and anti-pneumococcal potential against Klebsiella pneumoniae. LipCsP-Chitosan was synthesized by the ion gelation method and characterized by using a Malvern zetasizer and Fourier Transform Infrared (FTIR); CsP encapsulation and release kinetics were investigated. Anti-pneumococcal activity of the nanoformulations was accessed by agar-well diffusion and microdilution assays. LipCsP-chitosan exhibited a hydrodynamic size and zeta potential of 365.22 ± 0.70 nm and +39.30 ± 0.61 mV, respectively. CsP had an encapsulation efficiency of 81.5%. FTIR analysis revealed the interaction of the liposomes with chitosan and the CsP. A biphasic CsP release profile followed by a sustained release pattern was observed. LiPCsP-Chitosan presented a higher bioaccessibility of polyphenols in the simulated gastric phase (74.1% ± 1.3) than in the simulated intestinal phase (63.32% ± 1.00). LipCsP-chitosan had a relative inhibition zone diameter of 84.33% ± 2.51 when compared to CsP. At minimum inhibition concentration of 31.25 mg/mL, LipCsP-Chitosan reduced the viability of Klebsiella pneumoniae by 57.45% ± 3.76 after 24 h. The results obtained from the current study offer a new approach to the utilization of LipCsP-Chitosan as nanocarriers for candidate anti-pneumococcal agents.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Biochemical and Structural Characterization · Essential Oils and Antimicrobial Activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Nelson Mandela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania, Global Health and Biomedical Sciences, Arusha, Tanzania

Kenya Medical Research Institute, Center for Traditional Medicine and Drug Research, Nairobi, Kenya

UNESCO, National Commission of the United Republic of Tanzania, Dar-es-salaam, Tanzania

DSI/Mintek Nanotechnology Innovation Centre – Biolabels Node, Department of Biotechnology, University of the Western Cape, Cape Town, South Africa

Infectious Diseases Nanomedicine Laboratory, Faculty of Natural Sciences, Department of Pharmaceutical Sciences, University of the Western CapeCape Town, South Africa

References

Reference metadata was not supplied for this record.